Tuesday, 26 February 2019

Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from RSS Feeds : RSS Feed - NDTV Gadgets360.com https://ift.tt/2XjoJ5n
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

AI-Powered iOS 18 Could Be the Biggest Update in Apple's History: Report

Apple will introduce its newest iPhone 16 lineup, expected to be packed with Generative AI features, later this year. The Cupertino, Califor...